Japan · Delayed Price · Currency is JPY Chordia Therapeutics Statistics
Total Valuation
TYO:190A has a market cap or net worth of JPY 11.43 billion. The enterprise value is 8.98 billion.
| Market Cap | 11.43B |
| Enterprise Value | 8.98B |
Important Dates
The last earnings date was Tuesday, April 14, 2026.
| Earnings Date | Apr 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:190A has 73.73 million shares outstanding. The number of shares has increased by 8.20% in one year.
| Current Share Class | 73.73M |
| Shares Outstanding | 73.73M |
| Shares Change (YoY) | +8.20% |
| Shares Change (QoQ) | +3.40% |
| Owned by Insiders (%) | 2.67% |
| Owned by Institutions (%) | 25.20% |
| Float | 32.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.94 |
| P/TBV Ratio | 4.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.22 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.71 |
Financial Position
The company has a current ratio of 12.67
| Current Ratio | 12.67 |
| Quick Ratio | 12.41 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.90% and return on invested capital (ROIC) is -32.73%.
| Return on Equity (ROE) | -51.90% |
| Return on Assets (ROA) | -30.52% |
| Return on Invested Capital (ROIC) | -32.73% |
| Return on Capital Employed (ROCE) | -62.90% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -62.75M |
| Employee Count | 23 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TYO:190A has paid 2.16 million in taxes.
| Income Tax | 2.16M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.15% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -35.15% |
| 50-Day Moving Average | 131.20 |
| 200-Day Moving Average | 137.72 |
| Relative Strength Index (RSI) | 68.64 |
| Average Volume (20 Days) | 852,675 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.46B |
| Pretax Income | -1.44B |
| Net Income | -1.44B |
| EBITDA | -1.45B |
| EBIT | -1.46B |
| Earnings Per Share (EPS) | -20.64 |
Balance Sheet
The company has 2.45 billion in cash and n/a in debt, with a net cash position of 2.45 billion or 33.20 per share.
| Cash & Cash Equivalents | 2.45B |
| Total Debt | n/a |
| Net Cash | 2.45B |
| Net Cash Per Share | 33.20 |
| Equity (Book Value) | 2.32B |
| Book Value Per Share | 31.40 |
| Working Capital | 2.30B |
Cash Flow
In the last 12 months, operating cash flow was -1.33 billion and capital expenditures -4.66 million, giving a free cash flow of -1.34 billion.
| Operating Cash Flow | -1.33B |
| Capital Expenditures | -4.66M |
| Depreciation & Amortization | 2.83M |
| Net Borrowing | n/a |
| Free Cash Flow | -1.34B |
| FCF Per Share | -18.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TYO:190A does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.20% |
| Shareholder Yield | -8.20% |
| Earnings Yield | -12.63% |
| FCF Yield | -11.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |